Results 171 to 180 of about 3,097,210 (306)

Left ventricular diastolic dysfunction worsens prognosis in patients with heart failure due to dilated cardiomyopathy

ESC Heart Failure, Volume 12, Issue 2, Page 1183-1193, April 2025.
Abstract Aims The prognostic significance of left ventricular (LV) diastolic dysfunction (LVDD) severity in patients with dilated cardiomyopathy (DCM) remains uncertain. This study aimed to evaluate the association of LVDD severity and elevated left atrial pressure (eLAP) with patient outcomes in stable, non‐acutely decompensated patients with DCM ...
Mateusz Winiarczyk, Ewa Dziewięcka, Sylwia Wiśniowska‐Śmiałek, Agnieszka Stępień, Katarzyna Graczyk, Agata Leśniak‐Sobelga, Marta Hlawaty, Jakub Woźniak, Maryia Savitskaya, Katarzyna Holcman, Magdalena Kostkiewicz, Piotr Podolec, Paweł Rubiś   +12 more
wiley   +1 more source

Sudden death in the emergency department: A comprehensive 8-year study integrating clinical and autopsy data. [PDF]

Turk J Emerg Med
Akdemir T, Az A, Doğan Y, Akdemir E.
europepmc   +1 more source

Sudden Cardiac Death Among Hemodialysis Patients.

American Journal of Kidney Diseases, 2017
M. Makar, Patrick H. Pun
semanticscholar   +1 more source

Long‐term cardiovascular outcomes of immune checkpoint inhibitor‐related myocarditis: A large single‐centre analysis

ESC Heart Failure, Volume 12, Issue 2, Page 1237-1245, April 2025.
Abstract Aims Immune checkpoint inhibitors (ICI) are the cornerstone of modern oncology; however, side effects such as ICI‐related myocarditis (irM) can be fatal. Recently, Bonaca proposed criteria for irM; however, it is unknown if they correlate well with cardiovascular (CV) ICI‐related adverse events.
Lorenzo Braghieri, Ahmad Gharaibeh, Lubika Nkashama, Abdelrahman Abushouk, Osama Abushawer, Amir Mehdizadeh‐Shrifi, Bianca Honnekeri, Cassandra Calabrese, Venu Menon, Pauline Funchain, Patrick Collier, Diego Sadler, Rohit Moudgil   +12 more
wiley   +1 more source

Dose- and genotype-dependent cardiac arrhythmia and sudden death in rats following microdystrophin gene therapy. [PDF]

Mol Ther
Le Guiner C, Toumaniantz G, Larcher T, Marchand S, Buscara L, Cedrone G, Moreira CV, Lancelot A, Georger C, Lafoux A, Couzinié C, Augereau D, Jounier C, Hivonnait A, Creoff E, Blaie S, Huchet C, Adjali O, Daniele N, Perret G, Braun S.   +20 more
europepmc   +1 more source

Prognostic Value of Quantitative Contrast-Enhanced Cardiovascular Magnetic Resonance for the Evaluation of Sudden Death Risk in Patients With Hypertrophic Cardiomyopathy

Circulation, 2014
R. Chan, B. Maron, I. Olivotto, M. Pencina, G. Assenza, Tammy S. Haas, J. Lesser, C. Gruner, A. Crean, H. Rakowski, J. Udelson, E. Rowin, M. Lombardi, F. Cecchi, B. Tomberli, P. Spirito, Francesco Formisano, E. Biagini, C. Rapezzi, C. D. De Cecco, C. Autore, E. Cook, S. Hong, C. Gibson, W. Manning, E. Appelbaum, M. Maron   +26 more
semanticscholar   +1 more source

Effects of sodium–glucose co‐transporter inhibitors on individual clinical endpoints and quality of life

ESC Heart Failure, Volume 12, Issue 2, Page 1271-1282, April 2025.
Effects of SGLTi on Individual Clinical Endpoints and Quality‐of‐Life: outcome from randomized data. Abstract Aims Sodium–glucose co‐transporter inhibitors (SGLTis) have cardiovascular protective effects. We aimed to assess the effects of SGLTis on individual hard clinical endpoints and quality of life (QoL) in patients with cardiovascular risk factors.
Jia Liao, Yang Chen, Zhiyu Ling, Helmut Pürerfellner, Martin Martinek, Michael Derndorfer, Johannes Niel, Ramin Ebrahimi, Matthias Heukäufer, Sarah Janschel, Davide Di Vece, Klaus Empen, Astrid Hummel, Bishwas Chamling, Piotr Futyma, Fahim Ebrahimi, Márcio G. Kiuchi, Shaowen Liu, Yuehui Yin, Alexandra Schratter, Willem‐Jan Acou, Philipp Sommer, Boris Schmidt, Julian K. R. Chun, Christian Meyer, Marcus Dörr, Christian Templin, Shaojie Chen   +27 more
wiley   +1 more source

Hyperthermia-induced sudden death: Morphological insights from the lung and heart in an experimental study of Wistar rats. [PDF]

Open Vet J
Dervišević E, Šunjić I, Dervišević M, Sessa F, Spahović H, Bešić A, Krupić F, Ajanović T.   +7 more
europepmc   +1 more source

Considerations for drug trials in hypertrophic cardiomyopathy

ESC Heart Failure, Volume 12, Issue 2, Page 1095-1112, April 2025.
Abstract Hypertrophic cardiomyopathy (HCM) is a heterogeneous condition with potentially serious manifestations. Management has traditionally comprised therapies to palliate symptoms and implantable cardioverter‐defibrillators to prevent sudden cardiac death. The need for disease‐modifying therapies has been recognized for decades.
John P. Farrant, Matthias Schmitt, Anna B. Reid, Clifford J. Garratt, William G. Newman, Aneil Malhotra, Rhys Beynon, Masliza Mahmod, Betty Raman, Robert M. Cooper, Dana Dawson, Thomas Green, Sanjay K. Prasad, Anvesha Singh, Susanna Dodd, Hugh Watkins, Stefan Neubauer, Christopher A. Miller   +17 more
wiley   +1 more source

Burden of sudden death in young adults: A one-year observational study at a tertiary care centre in India. [PDF]

Indian J Med Res
Jain S, Gupta S, Murthy AS, Dagar S, Goswami A, Yadav A, Jain D, Suri V, Jana M, Gamanagatti S, Ray R, Prasad K, Tabin M, Tanwar S, Ranjan A, Roy A, Mohan A, Yadav S, Kumar S, Srivastava MVP, Vishnu VY, Sebastian LJD, Iyer VK, Lal V, Bahl A, Sharma SK, Dhaliwal RS, Kaur T, Sarkar C, Arava S.   +29 more
europepmc   +1 more source